MXPA04004915A - Nanoparticulas inorganicas para modificar la viscosidad y las propiedades fisicas de composiciones oftalmicas y oticas. - Google Patents

Nanoparticulas inorganicas para modificar la viscosidad y las propiedades fisicas de composiciones oftalmicas y oticas.

Info

Publication number
MXPA04004915A
MXPA04004915A MXPA04004915A MXPA04004915A MXPA04004915A MX PA04004915 A MXPA04004915 A MX PA04004915A MX PA04004915 A MXPA04004915 A MX PA04004915A MX PA04004915 A MXPA04004915 A MX PA04004915A MX PA04004915 A MXPA04004915 A MX PA04004915A
Authority
MX
Mexico
Prior art keywords
ophthalmic
modify
compositions
pharmaceutical compositions
viscosityand
Prior art date
Application number
MXPA04004915A
Other languages
English (en)
Inventor
Allen Ketelson Howard
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA04004915A publication Critical patent/MXPA04004915A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se a conocer el empleo de nano particulas de materiales inorganicos (por ejemplo, arcillas de esmectita sinteticas) en composiciones farmaceuticas, oftalmicas u oticas. Estas nanoparticulas se utilizan para modificar las propiedades reologicas de la composicion, asi como para aumentar la viscosidad, caracteristicas de flujo, lubricidad y otras caracteristicas de las composiciones. La invencion se dirige particularmente a la provision de composiciones lubricantes para el ojo y el oido, y para aumentar la viscosidad, adelgazamiento de corte de las composiciones de lagrimas artificiales.
MXPA04004915A 2001-12-21 2002-12-20 Nanoparticulas inorganicas para modificar la viscosidad y las propiedades fisicas de composiciones oftalmicas y oticas. MXPA04004915A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34296401P 2001-12-21 2001-12-21
PCT/US2002/041249 WO2003059263A2 (en) 2001-12-21 2002-12-20 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions.

Publications (1)

Publication Number Publication Date
MXPA04004915A true MXPA04004915A (es) 2004-08-11

Family

ID=23344065

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004915A MXPA04004915A (es) 2001-12-21 2002-12-20 Nanoparticulas inorganicas para modificar la viscosidad y las propiedades fisicas de composiciones oftalmicas y oticas.

Country Status (9)

Country Link
US (1) US20050002970A1 (es)
EP (1) EP1471925A2 (es)
JP (1) JP2005514433A (es)
KR (1) KR20040073503A (es)
AU (1) AU2002367030B2 (es)
BR (1) BR0215149A (es)
CA (1) CA2467764A1 (es)
MX (1) MXPA04004915A (es)
WO (1) WO2003059263A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059193A2 (en) * 2001-12-21 2003-07-24 Alcon, Inc. Use of nanoparticles as carriers for biocides in ophthalmic compositions
SI1474109T1 (sl) 2001-12-21 2010-11-30 Alcon Inc Uporaba sintetičnih anorganskih nanodelcev kot nosilcev za oftalmična zdravila
WO2004085998A2 (en) * 2003-03-28 2004-10-07 The Children's Hospital Of Philadelphia Biomimetic hierarchies using functionalized nanoparticles as building blocks
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
FR2867386B1 (fr) * 2004-03-09 2008-01-18 Armand Neumann Collyre constitue d'une eau argileuse filtree et purifiee de ses particules utilise, pour le traitement des glaucomes
US8703200B2 (en) * 2005-04-29 2014-04-22 The Board Of Regents Of The University Of Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
DE112006002042A5 (de) * 2005-05-18 2008-04-30 Mijo Ljubicic Mikronisierte mineralische Materialien und deren Herstellung
US10100266B2 (en) 2006-01-12 2018-10-16 The Board Of Trustees Of The University Of Arkansas Dielectric nanolubricant compositions
CA2636932C (en) 2006-01-12 2014-03-25 The Board Of Trustees Of The University Of Arkansas Nanoparticle compositions and methods for making and using the same
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
JP5462627B2 (ja) * 2006-09-05 2014-04-02 セリオン テクノロジー， インコーポレーテッド 二酸化セリウムナノ粒子を製造する方法
US20100021561A1 (en) * 2006-09-21 2010-01-28 Chowhan Masood A Self-preserved aqueous pharmaceutical compositions
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
CA2703820A1 (en) * 2007-10-30 2009-05-07 Unilever Plc Method of building viscosity and viscoelasticity in surfactant solutions by adding nanoparticles and compositions thereof
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
EP2151466A1 (en) * 2008-08-01 2010-02-10 SiNatur GmbH Biologically active silicic acid
EP2379738B1 (en) * 2008-12-31 2017-01-25 3M Innovative Properties Company Coliform detection process
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
WO2012036786A1 (en) 2010-09-17 2012-03-22 University Of L'aquila Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
EP2841055A4 (en) 2012-04-04 2015-09-16 Univ Duke METHODS OF USING CERIUM OXIDE NANOPARTICLES TO ATTENUATE OR PROTECT AGAINST RADIATION ATTACK
US8476206B1 (en) 2012-07-02 2013-07-02 Ajay P. Malshe Nanoparticle macro-compositions
US8486870B1 (en) 2012-07-02 2013-07-16 Ajay P. Malshe Textured surfaces to enhance nano-lubrication
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
US20140268028A1 (en) * 2013-03-15 2014-09-18 Johnson & Johnson Vision Care, Inc. Silicone-containing contact lens having clay treatment applied thereto
US20190054185A1 (en) * 2017-08-18 2019-02-21 King Fahd University Of Petroleum And Minerals Use of nano-sized clay crystallites to restore adhesion among tumor and aging stem cells

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3884826A (en) * 1973-07-20 1975-05-20 Barnes Hind Pharm Inc Thixotropic cleaning agent for hard contact lenses
US3974125A (en) * 1974-09-27 1976-08-10 Exxon Research And Engineering Company Higher dialkyl dimethyl ammonium clay gelling agents for unsaturated polyester compositions
US4127423A (en) * 1977-09-13 1978-11-28 Burton, Parsons And Company, Inc. Contact lens cleaning solution
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4394179A (en) * 1979-06-25 1983-07-19 Polymer Technology Corporation Abrasive-containing contact lens cleaning materials
US4374745A (en) * 1981-08-13 1983-02-22 Barnes-Hind Pharmaceuticals, Inc. Cleaning compositions
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
EP0217440A1 (en) * 1985-09-27 1987-04-08 The Procter & Gamble Company Stable aqueous pharmaceutical suspensions
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
WO1988004168A1 (en) * 1986-12-08 1988-06-16 Arseco, Inc. A storage stable topical composition
US4891043A (en) * 1987-05-28 1990-01-02 Board Of Trustees Of The University Of Illinois System for selective release of liposome encapsulated material via laser radiation
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5674504A (en) * 1989-07-12 1997-10-07 L'oreal Cosmetic composition in the form of an aqueous gel containing in suspension spheroids of a non-hydrophilic, lipoidal substance
US5185152A (en) * 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
CA2064160C (en) * 1991-03-27 1998-08-11 Paul J. T. Missel Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
EP0546728A3 (en) * 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
US5139782A (en) * 1991-12-23 1992-08-18 Uop Facial cleansing mineral compositions
US5394179A (en) * 1992-03-20 1995-02-28 Scitex Digital Printing, Inc. Stimulator for continous ink print head
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
ES2221921T3 (es) * 1992-07-13 2005-01-16 Shiseido Company, Ltd. Composicion para preparacion dermatologica.
US5532224A (en) * 1993-12-22 1996-07-02 Alcon Laboratories, Inc. Contact lens cleaning composition containing polyalklene oxide modified siloxanes
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US5585108A (en) * 1994-12-30 1996-12-17 Nanosystems L.L.C. Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
ES2238702T3 (es) * 1995-12-21 2005-09-01 Alcon Laboratories, Inc. Utilizacion de ciertos compuestos de isoquinolinsulfonilo en el tratamiento de glaucomas y de isquemias oculares.
US6015816A (en) * 1996-02-29 2000-01-18 The Research Foundation Of State University Of New York Antimicrobial compositions
WO1998011875A1 (en) * 1996-09-20 1998-03-26 Bausch & Lomb Incorporated Method and composition for rewetting contact lenses and relieving eye dryness
US5811580A (en) * 1996-12-04 1998-09-22 The Lubrizol Corporation Process for the preparation of N-hydrocarbyl-substituted amides via the ritter reaction using solid clay catalysts
WO1998025649A1 (en) * 1996-12-13 1998-06-18 Alcon Laboratories, Inc. Use of low molecular weight amino alcohols in ophthalmic compositions
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
ES2302881T3 (es) * 1997-07-29 2008-08-01 Alcon Laboratories, Inc. Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
JPH11281937A (ja) * 1998-03-27 1999-10-15 Menicon Co Ltd コンタクトレンズ用剤
JP2001240547A (ja) * 2000-02-29 2001-09-04 Lion Corp 花粉症抑制剤
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
SI1474109T1 (sl) * 2001-12-21 2010-11-30 Alcon Inc Uporaba sintetičnih anorganskih nanodelcev kot nosilcev za oftalmična zdravila

Also Published As

Publication number Publication date
BR0215149A (pt) 2004-10-19
WO2003059263A2 (en) 2003-07-24
WO2003059263A3 (en) 2003-12-04
AU2002367030A1 (en) 2003-07-30
EP1471925A2 (en) 2004-11-03
CA2467764A1 (en) 2003-07-24
AU2002367030B2 (en) 2008-10-16
US20050002970A1 (en) 2005-01-06
KR20040073503A (ko) 2004-08-19
JP2005514433A (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
MXPA04004915A (es) Nanoparticulas inorganicas para modificar la viscosidad y las propiedades fisicas de composiciones oftalmicas y oticas.
HK1075001A1 (en) Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
MXPA03008024A (es) Procedimiento para preparar aceite base lubricante.
WO2006002089A3 (en) Novel topical delivery system for plant derived anti-irritants
HRP20050845A2 (en) Prostaglandin analogs as ep4 receptor antagonists
ES2111507T3 (es) Fibras vitreas artificiales.
EP2154229A3 (de) Calcium/Lithium -Komplexfette, gekapseltes Gleichlaufgelenk enthaltend derartige Schmierfette, deren Verwendung und Verfahren zu deren Herstellung
SG152046A1 (en) Process to prepare a lubricating base oil and a gas oil
BRPI0506874A (pt) composições de xampu condicionante
BR0215245A (pt) Composição e método para fazer uma composição de alta fluidez aquosa de formulação estável, de múltiplas fases, para cuidado pessoal
CA2565157A1 (en) Unit dose detergent product comprising silicone oil
BR0116773A (pt) Composição na forma de uma dispersão aquosa
AR032803A1 (es) Una composicion de aceite base, su procedimiento de preparacion, formulacion lubricante que comprende el aceite base y su uso.
PT1148793E (pt) Metodo para a preparacao de microparticulas de fitoesterois ou fitoestanois
AR049440A1 (es) UN ARTICULO PARA LA LIMPIEZA QUE TIENE UNA COMPOSICIoN ESPUMABLE, QUE ES UN GEL SEMI-SOLIDO ELASTICO Y UNA CAPA FIBROSA
TW200716187A (en) Stick shape solid cosmetic material and method for making same
DE60230843D1 (de) Hydratisierte Natriumborat-Dispersionen mit verbesserten Eigenschaften in Schmierölzusammensetzungen
BRPI0407521A (pt) composição de óelo lubrificante, e, uso da mesma
CA2426923A1 (en) Dispersed hydrated potassium borate compositions having improved properties in lubricating oil compositions
MX2021004123A (es) Formulaciones de lactonas macrociclicas, procedimientos para su preparacion y uso de las formulaciones en el tratamiento de patologias secundarias a parasitos oftalmicos.
WO2007070690A3 (en) Lubricant composition with improved solvency
WO2002003916A3 (en) Compositions and methods for preparing dispersions of thickened oils
AR052199A1 (es) Composiciones para el tratamiento del cabello, metodo, uso y procedimiento para prepararlas
BR9708053A (pt) Suspensão aquosa composição a base de um ligante mineral composição de concreto e utilização de uma composição e de uma suspensão
WO2005056515A3 (en) Use of bis-amines to enhance the antimicrobial activity of aqueous compositions

Legal Events

Date Code Title Description
FA Abandonment or withdrawal